- 英文名称
- Everolimus-d4
- 分子式
- C53H79D4NO14
- 分子量
- 962.25
- 中文别名
- 依维莫司杂质24; 依维莫司杂质11; [2H4]-依维莫司; 依维莫司(2-羟乙基-D4,98%); 依维莫司(2-羟乙基-D4); 依维莫司-D4; 依维莫司-[D4]; Everolimus Impurity 24; Everoliums-d4; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-((R)-1-((1S,3R,4R)-4-(2-hydroxyethoxy-1,1,2,2-d4)-3-methoxycyclohexyl)propan-2-yl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentaone; (1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4R)-3-methoxy-4-(1,1,2,2-tetradeuterio-2-hydroxyethoxy)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- 用途
- 示踪分析试剂;Everolimus-d4 是 Everolimus 的氘代物,Everolimus 是 Rapamycin 衍生物,作为有效的、选择性的口服活性 mTOR1 抑制剂,与 FKBP-12 结合产生免疫抑制复合物,抑制肿瘤细胞增殖并诱导凋亡和自噬,具有免疫抑制和抗癌活性。